98%
921
2 minutes
20
Background: Helicobacter pylori (H. pylori) has been strongly associated with gastroduodenal pathologies, including gastritis, peptic ulcers, and gastric cancer. This study aimed to determine the prevalence of H. pylori infection in Khuzestan Province, Southwest Iran, identify demographic and clinical predictors, and evaluate the effect of proton pump inhibitors (PPIs), antibiotics, and bismuth on the accuracy of diagnostic tests.
Methods And Results: In this cross-sectional study, 550 patients (aged 12-94 years) with gastrointestinal disorders underwent upper endoscopy. Demographic data, medication history, and endoscopic findings were recorded. Four antral biopsies per patient were collected and analyzed for H. pylori infection using the rapid urease test (RUT), histology, culture, and polymerase chain reaction (PCR) for confirmatory testing. Univariate logistic regression assessed the effects of medications on diagnostic results. The overall prevalence of H. pylori infection was 51.8% (285/550). Histology demonstrated higher sensitivity than RUT and culture. After adjustment for age and sex, the 31-40-year and 41-50-year age groups exhibited significantly higher odds of infection compared to the ≤ 30-year reference group. Multivariate analysis identified melena, duodenal ulcer, antral nodularity, and hiatal hernia as independent predictors of infection. Recent use of PPIs, antibiotics, or bismuth reduced the sensitivity of both RUT and histology; however, histology retained greater diagnostic reliability.
Conclusions: The high prevalence of H. pylori infection in Khuzestan Province emphasizes the development of eradication programs. Melena, duodenal ulcer, and antral nodularity are key clinical predictors. The novel association between H. pylori infection and hiatal hernia requires further studies to understand the underlying mechanisms. When discontinuing PPIs, antibiotics, or bismuth before testing is impractical in order to minimize false negatives, combining PCR with histology can improve diagnostic accuracy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s11033-025-10905-5 | DOI Listing |
J Ayurveda Integr Med
September 2025
Department of Gastroenterology, Lala Lajpat Rai Memorial Medical College, Meerut, India.
Background: The most common cause of acid-peptic diseases (APDs) is Helicobacter Pylori (H. pylori) infection. Conventionally, proton-pump inhibitors (PPIs) are used to manage hyperacidity and dyspepsia.
View Article and Find Full Text PDFInn Med (Heidelb)
September 2025
Klink für Innere Medizin, Gastroenterologie und Diabetologie, Niels-Stensen-Kliniken Marienhospital Osnabrück, Osnabrück, Deutschland.
Helicobacter pylori was first characterized as an obligate bacterial pathogen in 1983. Since then, substantial advances have been made in understanding the pathophysiology of H. pylori infection, optimizing diagnostic and therapeutic strategies, and expanding testing and treatment-including in the prevention of gastric malignancies.
View Article and Find Full Text PDFCurr Opin Gastroenterol
July 2025
Division of Gastroenterology, Washington University School of Medicine, St. Louis, Missouri, USA.
Purpose Of Review: Acid suppression is the mainstay of management of common foregut disorders, including gastroesophageal reflux disease (GERD), peptic ulcer disease and Helicobacter pylori infection. Drawbacks of standard management with proton pump inhibitors (PPIs) include acid lability requiring enteric coating, slow onset of effect, lack of suppression of nocturnal acid breakthrough, and need for administration before meals.
Recent Findings: Potassium-competitive acid blockers (PCABs) are a novel class of acid suppressants that are effective in the management of symptomatic and erosive GERD, peptic ulcer disease and H.
Cancer Biol Med
September 2025
State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Objective: The key molecular events signifying the -induced gastric carcinogenesis process are largely unknown.
Methods: Bulk tissue-proteomics profiling were leveraged across multi-stage gastric lesions from Linqu ( = 166) and Beijing sets ( = 99) and single-cell transcriptomic profiling ( = 18) to decipher key molecular signatures of -related gastric lesion progression and gastric cancer (GC) development. The association of key proteins association with gastric lesion progression and GC development were prospectively studied building on follow-up of the Linqu set and UK Biobank ( = 48,529).
Medicine (Baltimore)
September 2025
Department of Gastrointestinal Surgery, The Wujin Hospital Affiliated with Jiangsu University, Changzhou, China.
To date, evidence on the relationship between H. pylori infection and biliary diseases remains unclear. This Mendelian randomization (MR) study aim to investigate the causal relationship between H.
View Article and Find Full Text PDF